Astrazeneca: Accelerating Drug Discovery With Machine Learning And Ai On Cambridge-1

AstraZeneca: Accelerating Drug Discovery with Machine Learning and AI on Cambridge-1

Uniting human and machine intelligence for drug discovery in CKD

Revolutionising drug discovery with AI

Machine learning and AI across discovery sciences

Machine learning and AI to interrogate complex diseases

AI for Drug Discovery with AstraZeneca

Unlocking the potential of data & AI driven drug discovery and development

Uniting human and machine intelligence for drug discovery in IPF

How AI is accelerating drug discovery - Nature's Building Blocks | BBC StoryWorks

Combining CRISPR and AI to accelerate cancer drug discovery

Inside AstraZeneca's new £1bn R&D site in Cambridge - The Discovery Centre (DISC)

The curiosity behind drug discovery – Abdou

Dr. Jon-Paul Janet -- Accelerating drug design with AI & simulation

Chalmers AI4Science

Better, faster, and cheaper drug discovery with machine learning by AstraZeneca

GAIA

Accelerate AI-Powered Drug Discovery With NVIDIA BioNeMo

Olexandr Isayev - Accelerating Drug Discovery with Machine Learning and AI

Bioinformatics Seminar Series at Purdue CS

Tour of the New AstraZeneca Building, Cambridge UK

Milner Therapeutics Institute

Our guiding principles in data science and AI

Accelerating Drug Discovery With a Biomedical Knowledge Graph

Jon Paul Janet | AstraZeneca AB - Accelerating drug design with AI & simulation